Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
438.00    -1.80 (-0.41%)
Bid:
440.20
Ask:
441.00
Spread: 0.80 (0.182%)
Market Cap: £2.25b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Total Voting Rights

30 Jun 2025 16:00

RNS Number : 0389P
QinetiQ Group plc
30 June 2025
 

QinetiQ Group plc

Total Voting Rights

 

30 June 2025 - In accordance with the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rule 5.6.1R, QinetiQ Group plc ("the Company") notifies the market that as of 30 June 2025 the Company's issued ordinary share capital consists of 544,327,145 ordinary shares of one penny each. There are no shares held in treasury. 

Therefore, the total number of voting rights in the Company is 544,327,145. This figure may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

About QinetiQ:

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

 

For further information, please contact:

Stephen Lamacraft, Interim Group Investor Relations Director:

+44 (0) 7920 545841

Stephanie Mann, Group Head of Media Relations:

+44 (0) 7770 720268

James Field, Company Secretary:

+44 (0) 7841 662957

 

QinetiQ Group plc LEI: 213800S8OBDOZMCMUW34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBSGDLBXXDGUG
Date   Source Headline
23rd Jun 20179:40 amRNSDirector/PDMR Shareholding
21st Jun 20175:08 pmRNSDirector/PDMR Shareholding
13th Jun 20173:55 pmRNSAnnual Financial Report
12th Jun 20172:56 pmRNSDirector/PDMR Shareholding
25th May 20177:00 amRNSFull Year Results 2017
10th May 20174:00 pmRNSDirector/PDMR Shareholding
5th May 20174:42 pmRNSBlock listing Interim Review
12th Apr 20174:12 pmRNSDirector/PDMR Shareholding
31st Mar 20173:03 pmRNSTotal Voting Rights
28th Mar 20171:47 pmRNSTransaction in Own Shares 27 Mar 17 - Replacement
27th Mar 20175:48 pmRNSTransaction in Own Shares
24th Mar 20175:13 pmRNSTransaction in Own Shares
23rd Mar 20175:34 pmRNSTransaction in Own Shares
22nd Mar 20175:45 pmRNSTransaction in Own Shares
21st Mar 20175:31 pmRNSTransaction in Own Shares
20th Mar 20175:18 pmRNSTransaction in Own Shares
17th Mar 20175:53 pmRNSTransaction in Own Shares
16th Mar 20175:49 pmRNSTransaction in Own Shares
10th Mar 20173:17 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSTotal Voting Rights
27th Feb 20175:01 pmRNSTransaction in Own Shares
24th Feb 20175:09 pmRNSTransaction in Own Shares
23rd Feb 20175:08 pmRNSTransaction in Own Shares
22nd Feb 20175:20 pmRNSTransaction in Own Shares
21st Feb 20175:12 pmRNSTransaction in Own Shares
15th Feb 20177:00 amRNSThird Quarter Trading Update
13th Feb 20173:00 pmRNSDirector/PDMR Shareholding
10th Feb 20171:51 pmRNSDirector/PDMR Shareholding
31st Jan 20175:06 pmRNSTransaction in Own Shares
31st Jan 201711:00 amRNSTotal Voting Rights
30th Jan 20175:19 pmRNSTransaction in Own Shares
27th Jan 20175:05 pmRNSTransaction in Own Shares
26th Jan 20175:08 pmRNSTransaction in Own Shares
26th Jan 20178:00 amRNSChange of Auditor
25th Jan 20175:19 pmRNSTransaction in Own Shares
24th Jan 20175:22 pmRNSTransaction in Own Shares
16th Jan 20174:17 pmRNSDirector/PDMR Shareholding
10th Jan 20174:04 pmRNSDirector/PDMR Shareholding
6th Jan 20179:47 amRNSConfirmation of Date of Appointment of CFO
21st Dec 20167:00 amRNSQinetiQ acquires Meggitt Target Systems
12th Dec 20164:11 pmRNSDirector/PDMR Shareholding
12th Dec 20164:09 pmRNSDirector/PDMR Shareholding
12th Dec 20164:06 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSQinetiQ secures £1bn LTPA contract amendment
1st Dec 20167:00 amRNSTotal Voting Rights
17th Nov 20167:00 amRNSHalf-year Report
11th Nov 201610:44 amRNSDirector/PDMR Shareholding
11th Nov 201610:40 amRNSDirector/PDMR Shareholding
2nd Nov 20165:00 pmRNSTransaction in Own Shares
1st Nov 201610:46 amRNSTotal Voting Rights - Amending Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.